Patient-volunteer studies in Multiple Sclerosis
Hot off the press ...
just published and co-authored by Dr Wolf:
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study.
Christian Wolf, Jagdev Sidhu, Christian Otoul, Dexter L. Morris, Jennifer Cnops, Jörg Täubel, Barbara Bennett.
PLoS One. 2013; 8(3):e58438 (full text).